Rituximab in routine care of severe active rheumatoid arthritis-Reference-Cited by-同舟云学术

Rituximab in routine care of severe active rheumatoid arthritis

Published:2018-10-01 Issue:9 Volume:78 Page:881-888
ISSN:0340-1855
Container-title:Zeitschrift für Rheumatologie
language:en
Short-container-title:Z Rheumatol

Author:

Krause A.,Aries P. M.,Berger S.,Fiehn C.,Kellner H.,Lorenz H.-M.,Meier L.,Müller G. A.,Müller-Ladner U.,Schwarting A.,Tony H.-P.,Peters M. A.,Wendler J.

Publisher

Springer Science and Business Media LLC

Subject

Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s00393-018-0552-0.pdf

Reference25 articles.

1. Chatzidionysiou K, Lie E, Nasonov E et al (2016) Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration. Arthritis Res Ther 18:50

2. Chatzidionysiou K, Lie E, Nasonov E et al (2011) Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries. Ann Rheum Dis 70:1575–1580

3. Chatzidionysiou K, Lie E, Nasonov E et al (2012) Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration. Ann Rheum Dis 71:374–377

4. Cohen MD, Keystone E (2015) Rituximab for rheumatoid arthritis. Rheumatol Ther 2:99–111

5. Cohen SB, Emery P, Greenwald MW et al (2006) Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum 54:2793–2806

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term drug effectiveness and survival for reference rituximab in rheumatoid arthritis patients in an ordinary outpatient clinic;Scientific Reports;2022-05-18

2. Low-dose rituximab protocol in rheumatoid arthritis—outcome and economic impact;Rheumatology Advances in Practice;2021

3. Woody vegetation damage by the African elephant during severe drought at Pongola Game Reserve, South Africa;African Journal of Ecology;2020-05-16

4. Real-world use and acceptance of rituximab biosimilars in non-Hodgkin lymphoma in an oncologist network in Germany;Future Oncology;2020-05

5. Parameter Optimization of Water Distribution Network – A Hybrid Metaheuristic Approach;Materials and Manufacturing Processes;2020-01-26